Background illustration for clinical trials search

Lupus Clinical Trials

Browse 173 Lupus clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

HEALTH Home Urinalysis Testing

for
Systemic Lupus Erythematosus
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT07823478

Recruiting

FT839 in Autoimmune Diseases

for
ANCA-Associated Vasculitis (AAV),
Location: Fullerton CA
Sponsor: Fate Therapeutics

Sex: All

Age: 18 - 70

Code: NCT07800871

Phase 1, Phase 2, Recruiting

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

for
Systemic Lupus Erythematosus
Location: Fayetteville NC, Aventura FL, Duncansville PA, Tampa FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18 - 70+

Code: NCT07409181

Phase 2, Recruiting

CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

for
Systemic Lupus Erythematosus
Location: Waltham MA
Sponsor: CorEvitas

Sex: All

Age: 18+

Code: NCT06804057

Recruiting

Anifrolumab Pregnancy Study

for
Systemic Lupus Erythematosus
Location: Cary NC
Sponsor: AstraZeneca

Sex: Female

Age: 18 - 70+

Code: NCT07049653

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Biopsychosocial Risk Influences on the Development and Generation of Early-Onset Chronic Pain

for
Juvenile Idiopathic Arthritis (JIA), Fibromyalgia, Lupus,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 14 - 26

Code: NCT07602595

Recruiting

Complete Cognitive Intervention for cSLE

for
Lupus
Location: Toronto
Sponsor: Andrea Knight

Sex: All

Age: 13 - 18

Code: NCT07302113

Recruiting

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

for
Systemic Lupus Erythematosus (SLE),
Location: New York NY, Oklahoma City OK
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 70+

Code: NCT06875960

Recruiting

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

for
Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus
Location: Smithfield NC, Hollywood FL, Fort Lauderdale FL,
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07355218

Phase 3, Recruiting

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

for
Systemic Lupus Erythematosus
Location: San Antonio TX, Allen TX
Sponsor: Climb Bio, Inc.

Sex: All

Age: 18 - 65

Code: NCT07011043

Phase 1, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: New York NY, East Brunswick NJ, Montreal, Baltimore MD,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07085104

Phase 1, Recruiting

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

for
Systemic Lupus Erythematosus,
Location: Boston MA, Great Neck NY, New York NY, Rochester NY,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT06570798

Phase 2, Recruiting

BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus
Location: Columbus OH
Sponsor: Luminary Therapeutics

Sex: All

Age: 18 - 65

Code: NCT06340750

Phase 1, Recruiting

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

for
Systemic Lupus Erythematosus
Location: New Hyde Park NY, Valhalla NY, The Bronx NY,
Sponsor: AstraZeneca

Sex: All

Age: 5 - 17

Code: NCT05835310

Phase 3, Recruiting

Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE

for
Systemic Lupus Erythematosus (SLE)
Location: Oklahoma City OK
Sponsor: Oklahoma Medical Research Foundation

Sex: All

Age: 18 - 70

Code: NCT04726553

Early Phase 1, Recruiting

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

for
Systemic Lupus Erythematosus (Sle),
Location: Bethesda MD
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Sex: Female

Age: 18 - 70+

Code: NCT05567198

Recruiting

Safety of the Herpes Zoster Subunit Vaccine in Lupus

for
Systemic Lupus Erythematosus
Location: New York NY, Oklahoma City OK
Sponsor: NYU Langone Health

Sex: All

Age: 18 - 70+

Code: NCT05559671

Phase 4, Recruiting

Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)

for
Lupus Erythematosus, Systemic
Location: Manhasset NY, Charlotte NC, Los Angeles CA
Sponsor: Ampel BioSolutions, LLC

Sex: All

Age: 18+

Code: NCT05845593

Recruiting

REACT-01: Reversing Autoimmunity Through Cell Therapy

for
Systemic Lupus Erythematosus
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 2 - 30

Code: NCT06465147

Phase 1, Recruiting

At the Heart of the Matter - Speckle Tracking Echocardiography in Lupus Mothers and Their Offspring

for
Systemic Lupus Erythematosus,
Location: Montreal
Sponsor: Evelyne Vinet

Sex: Female

Age: 18 - 45

Code: NCT05451277

Recruiting

What is lupus?

Lupus is an autoimmune disease in which the immune system attacks the body's own tissues. Systemic lupus erythematosus, or SLE, the most common type, can affect the skin, joints, kidneys, blood, heart, lungs, and brain, and typically comes in flares of fatigue, joint pain, rashes, and fever. Women of childbearing age are at highest risk, and Black and American Indian or Alaska Native women are two to three times more likely than White women to develop it. Cutaneous lupus affects mainly the skin, and kidney involvement is covered on our lupus nephritis page. Treatment starts with hydroxychloroquine and adds steroids, immune suppressants, and biologics as needed; belimumab, approved in 2011, was the first new lupus drug in more than 50 years.

Lupus overlaps with other autoimmune disorders such as scleroderma and rheumatoid arthritis. Cell therapy is explained on our CAR T cell therapy page.

Types of lupus clinical trials

Who can participate in lupus clinical trials?

Forms of lupus, and why they matter for trials

How to enroll in a lupus clinical trial